The PREPARE study: benefits of pharmacogenetic testing are unclear
Lancet
.
2023 Jun 3;401(10391):1851.
doi: 10.1016/S0140-6736(23)00855-3.
Author
Lorenz Van der Linden
1
Affiliation
1
Hospital Pharmacy Department, University Hospitals Leuven, Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium. Electronic address: lorenz.vanderlinden@uzleuven.be.
PMID:
37270237
DOI:
10.1016/S0140-6736(23)00855-3
No abstract available
Publication types
Letter
Comment
MeSH terms
Genetic Testing*
Humans
Pharmacogenetics
Pharmacogenomic Testing*